Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
PCOS-related obesity GLP-1 injectables were administered to women with known PCOS disease for a period of 3 months
This dual action means tirzepatide sends hunger-suppressing signals through two separate channels in the brain and body
When giving yourself a Sembolic injection, choose a spot on your abdomen, at least 2 inches away from your belly button
Individuals with the following conditions may be at heightened risk and should be assessed carefully: Pre-existing arrhythmias , including atrial fibrillation or supraventricular tachycardia, given the drug's association with elevated resting heart rate Heart failure , particularly where heart rate control is a key management goal Ischaemic heart disease , where any increase in myocardial oxygen demand could be clinically significant Uncontrolled hypertension , although retatrutide may itself reduce blood pressure over time Patients on rate-modifying medications such as beta-blockers or calcium channel blockers whilst no direct pharmacokinetic drugdrug interactions have been established, the heart rate effects of retatrutide may complicate clinical management and require closer monitoring Patients with a recent acute coronary syndrome, decompensated heart failure, or unstable angina are typically excluded from clinical trials of this class of agent
The most important distinction: Zepbound is a weight-management medication
